MetaCap

Century Therapeutics Inc. Company Profile

NASDAQ: IPSCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.28-0.04 (-3.03%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 1.28 0.00%

Century Therapeutics at a glance

Century Therapeutics Inc. (NASDAQ: IPSC) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $239.0 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001850119, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

Company information

Legal name
Century Therapeutics Inc.
Ticker
NASDAQ: IPSC
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Headquarters
United States
IPO year
2021
Market cap
$239.02M
SEC CIK
0001850119

Companies similar to Century Therapeutics

IPSC peer companies
CompanyPrice% ChgMarket capCompare
LCTXLineage Cell Therapeutics Inc.0.9476+1.03%$239.66Mvs IPSC
STROSutro Biopharma Inc.14.66+1.45%$243.08Mvs IPSC
FATEFate Therapeutics Inc.2.15-6.11%$257.61Mvs IPSC
PALIPalisade Bio Inc.1.48-0.67%$257.92Mvs IPSC
PLXProtalix BioTherapeutics Inc. (DE)2.71-0.73%$218.35Mvs IPSC
SABSSAB Biotherapeutics Inc.2.88-1.71%$262.04Mvs IPSC
IVVDInvivyd Inc.0.7286-9.65%$214.76Mvs IPSC
ALECAlector Inc.1.92+6.08%$214.38Mvs IPSC

Related